Scientific Rigor
Evidence over hype—peer-reviewed performance at every step of translation.
Academic Partnerships
Work With Us
We partner with world-class academic institutions to rapidly commercialize breakthrough research—bringing innovative diagnostics, therapeutics, and research tools from the lab to market.
How We Partner
- Collaborate Work with our team and academic investigators to identify high-impact discoveries with clear paths to commercialization.
- Prototype Apply rapid-prototype platforms—microfluidics, single-cell analysis, and multi-omics—to validate and de-risk breakthrough science.
- Commercialize Move validated innovations toward accessible diagnostics, therapeutics, and research tools that improve public health.
What We Bring
Three scientific platforms that support rigorous translation from discovery to impact.
Functional Biology
We use high throughput single-cell analysis, advanced microdroplet technologies, and novel NGS techniques to elucidate fundamental biological processes and understand their dysregulation in disease.
Multi Omics
We deliver innovative, integrative, and impactful insights that can only be derived using a multi-omic approach encompassing genomics, transcriptomics, and proteomics in a single assay.
Rapid Viral Detection
Our technology platform enables quantification of pathogens rapidly and sensitively, even at low viral loads or in complex samples.
Our Values
As a public benefit corporation, we hold ourselves to standards that prioritize patient outcomes alongside scientific and commercial success.
Patient Impact
Innovations designed to reach patients, clinicians, and labs with real-world utility.
Collaboration
Born in the lab and built with academic partners, investors, and the broader scientific community.
Openness
Transparent communication and open scientific collaboration as we move from bench to bedside.